Science on Target Blog Target ALS Thought Leadership Pioneering the Next Generation of ALS Therapeutics: Announcing the 2025 Novel Modalities Consortia GranteesREAD MORETofersen Shows Promising Results in SOD1 ALS Treatment—A New Hope for Genetic TherapiesREAD MOREDigital Biomarkers – An Opportunity to Overcome the Limits of Traditional Rating Scales?READ MOREResearchers Report on the Opposing Roles of p38α Phosphorylation and Protein Arginine Methyltransferase 1 (PRMT1) Methylation in TDP-43 ProteinopathyREAD MOREUpdates from our Research Cores: Expanding our Cellular Model ToolkitREAD MOREScience on Target: Target ALS Postmortem Tissue Core Facilitates Groundbreaking Research on SOD1 Protein AggregationREAD MORELoad MoreThe Innovation EcosystemTrailblazing a New Frontier in ALS Treatment: Dr. Claire Clelland’s Bold CRISPR Strategy to Rewrite the FutureREAD MOREUnlocking ALS Risk in South Asian Populations: Inside a Groundbreaking Genetic Study Led by India and the UKREAD MORETurning Sight into Insight: How Amydis Is Using the Retina to Rethink ALS Screening and Diagnostics READ MOREExpanding the Frontiers of ALS Research: South Korea Joins the Target ALS Global StudyREAD MOREAdvancing ALS Research in India Through Global CollaborationREAD MOREBridging Worlds: Volkan Granit and the Unique Collaborative Spirit of Target ALSREAD MORELoad More
